Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Options for Protease Inhibitor-exposed Children

NCT01146873 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT01146873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01146873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Options for Protease Inhibitor-exposed Children
Lead sponsor
Columbia University
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2010
Completion date
December 31, 2014
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, hiv/aids